Cullinan Therapeutics, Inc. CGEM Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s operating lease liabilities?
- Cullinan Therapeutics, Inc. (CGEM) reported operating lease liabilities of $1.66M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Cullinan Therapeutics, Inc.'s operating lease liabilities increased by 236.3% year-over-year, from $493K to $1.66M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s operating lease liabilities has grown at a 21.6% compound annual growth rate (CAGR), from $871K to $1.9M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.